IndraLab
Statements
reach
"In isolated rat hearts subjected to I/R, metformin reduced the size of the infarct and inhibited cardiac fibrosis through the reduction of proinflammatory cytokines (TNF-α, IL-6, IL-1β) and the suppression of the activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome [11]."
reach
"In addition, metformin, a drug widely used for diabetes, was reported to indirectly inhibit the NLRP3 inflammasome via the regulation of the mechanistic target of rapamycin mechanistic target of rapamycin kinase (mTOR) protein, which is related to the reduction in the mortality of COVID-19 and type 2 diabetes mellitus (T2DM) patients [149]."
reach
"[55]
Besides, metformin a first-line drug in the management of T2DM, acts through activation of AMP-activated protein kinase (AMPK) and blocking of mitochondrial complex I. [56] Metformin inhibits NLRP3 inflammasome through AMPK activation and autophagy with mTOR pathway inhibition in dilated cardiomyopathy."
reach
"Although metformin attenuated mtROS accumulation in macrophages treated with the NLRP3 activators ATP and nigericin, this effect was not important for inhibition of NLRP3 inflammasome activation which was not reversed by treatment of metformin incubated macrophages with the mtROS generators mitoParaquat and DMNQ."
| PMC
reach
"Metformin is used for treating type 2 diabetes either alone or in combination with other hypoglycemic agents.122 Yang et al reported that metformin blocks the NLRP3 inflammasome through inhibition of the AMPK/mTOR pathway, and improves cardiac fibrosis in mice with diabetic cardiomyopathy.123 Empaglifozin (EMPA) selectively inhibits the sodium-glucose co-transporter 2."
reach
"[55] Besides, metformin a first-line drug in the management of T2DM, acts through activation of AMP-activated protein kinase (AMPK) and blocking of mitochondrial complex I. [56] Metformin inhibits NLRP3 inflammasome through AMPK activation and autophagy with mTOR pathway inhibition in dilated cardiomyopathy."
| DOI
reach
"Our data report that metformin effectively inhibits the activation of TNC microglia and NLRP3 while alleviating the inflammatory response.Studies have demonstrated that LPS stimulation causes an elevation of TREM2 expression in mouse primary cultured microglia and facilitates neuroinflammatory processes [50]."
reach
"Among the last ones, a remarkable effect of metformin in preventing LPS-induced IL-1β mRNA levels was found, thus further supporting our in vitro study showing that metformin highly inhibits NLRP3 inflammasome priming in microglia.Under brain pathological conditions, microglial checkpoints pathways sense the environment to prevent overreaction to external stimuli."
reach
"Metformin, the most widely used drug for treating T2D, can inhibit NLRP3 by activating AMPK (AMP activated protein kinase), thus increasing autophagy activity to promote the clearance of inflammasomes via inhibiting the mTOR pathway and alleviating the symptoms in diabetic cardiomyopathy."
reach
"Additionally, metformin inhibits the NLRP3 inflammasome, decreasing IL-1β release by stabilizing mitochondrial function and reducing reactive oxygen species (ROS), a mechanism confirmed in metabolic disease models but applicable to infection-related inflammation (Xian et al., 2021)."
reach
"Therefore, we demonstrated that metformin inhibits the NLRP3 pathway via mitochondrial complex I/AMPK/mTOR-dependent effects in diabetic mice.In conclusion, our findings strongly demonstrate that metformin possesses cardioprotective and anti-inflammatory effects by activating AMPK/autophagy and subsequently inhibiting the NLRP3 inflammasome in DCM."